Green Daniel M
Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee.
Pediatr Blood Cancer. 2016 Apr;63(4):589-92. doi: 10.1002/pbc.25840. Epub 2015 Dec 2.
More than 70% of children with stage IV, favorable histology (FH) Wilms tumor will be relapse-free survivors 16 years after diagnosis. Successful treatment generally includes whole lung radiation therapy and doxorubicin. Such therapy is associated with adverse, long-term effects, including impaired pulmonary function, congestive heart failure, and second malignant neoplasms, especially breast cancer. Cooperative groups have adopted a risk-based approach to the treatment of these patients. It is important to recall the good overall prognosis for this group before recommendations for intensification are made based on preliminary data and in the absence of histological confirmation of persistent malignant disease.
超过70%的IV期、组织学良好(FH)的威尔姆斯瘤患儿在诊断后16年将成为无复发生存者。成功的治疗通常包括全肺放射治疗和阿霉素。这种治疗会带来不良的长期影响,包括肺功能受损、充血性心力衰竭和第二原发性恶性肿瘤,尤其是乳腺癌。协作组已采用基于风险的方法来治疗这些患者。在根据初步数据且未得到持续性恶性疾病组织学确认就提出强化治疗建议之前,重要的是要记住该组患者总体预后良好。